Evaluating programs for diabetes and kidney disease management.
NIDDK - EVALUATION OF NIDDK OMHRC PROGRAMS - NMA AND NMRI AND HARP
['FUNDING_OTHER'] · RIPPLE EFFECT COMMUNICATIONS, INC. · NIH-11137543
This study is looking at different programs designed to help people with diabetes and kidney diseases, so that patients can get better care and support to manage their health.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | RIPPLE EFFECT COMMUNICATIONS, INC. (nih funded) |
| Locations | 1 site (ROCKVILLE, UNITED STATES) |
| Trial ID | NIH-11137543 on ClinicalTrials.gov |
What this research studies
This research evaluates various programs developed by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) aimed at improving health outcomes for patients with diabetes and kidney diseases. The evaluation will focus on assessing the effectiveness of these programs in managing and preventing complications associated with these conditions. Patients may benefit from insights gained through this evaluation, which could lead to improved treatment strategies and resources tailored to their needs.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with diabetes or kidney-related conditions who are engaged in or affected by the NIDDK programs being evaluated.
Not a fit: Patients without diabetes or kidney diseases, or those not involved in the NIDDK programs, may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to enhanced programs that improve the management and outcomes of diabetes and kidney diseases for patients.
How similar studies have performed: Previous evaluations of similar health programs have shown success in improving patient outcomes, indicating that this approach is promising.
Where this research is happening
ROCKVILLE, UNITED STATES
- RIPPLE EFFECT COMMUNICATIONS, INC. — ROCKVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: NA, NA — RIPPLE EFFECT COMMUNICATIONS, INC.
- Study coordinator: NA, NA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: National Institute of Diabetes and Digestive and Kidney Diseases